BR9703338A - 2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm - Google Patents

2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm

Info

Publication number
BR9703338A
BR9703338A BR9703338A BR9703338A BR9703338A BR 9703338 A BR9703338 A BR 9703338A BR 9703338 A BR9703338 A BR 9703338A BR 9703338 A BR9703338 A BR 9703338A BR 9703338 A BR9703338 A BR 9703338A
Authority
BR
Brazil
Prior art keywords
medicine
naftoil
diagnosis
preparation
well
Prior art date
Application number
BR9703338A
Other languages
English (en)
Portuguese (pt)
Inventor
Bansi Lal
Heinrick Christian Englert
Hans Jochen Lang
Joachim Brendel
Jan-Robert Schwark
Heinz Werner Kleemann
Andreas Weichert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9703338A publication Critical patent/BR9703338A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
BR9703338A 1996-05-29 1997-05-30 2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm BR9703338A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19621483A DE19621483A1 (de) 1996-05-29 1996-05-29 Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
BR9703338A true BR9703338A (pt) 1998-08-18

Family

ID=7795549

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9703338A BR9703338A (pt) 1996-05-29 1997-05-30 2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm

Country Status (29)

Country Link
US (1) US6087304A (cg-RX-API-DMAC7.html)
EP (1) EP0810206B1 (cg-RX-API-DMAC7.html)
JP (1) JP4039588B2 (cg-RX-API-DMAC7.html)
KR (1) KR970074776A (cg-RX-API-DMAC7.html)
CN (1) CN1167759A (cg-RX-API-DMAC7.html)
AR (1) AR008373A1 (cg-RX-API-DMAC7.html)
AT (1) ATE198320T1 (cg-RX-API-DMAC7.html)
AU (1) AU710065B2 (cg-RX-API-DMAC7.html)
BR (1) BR9703338A (cg-RX-API-DMAC7.html)
CA (1) CA2206366C (cg-RX-API-DMAC7.html)
CZ (1) CZ163097A3 (cg-RX-API-DMAC7.html)
DE (2) DE19621483A1 (cg-RX-API-DMAC7.html)
DK (1) DK0810206T3 (cg-RX-API-DMAC7.html)
ES (1) ES2154002T3 (cg-RX-API-DMAC7.html)
GR (1) GR3035126T3 (cg-RX-API-DMAC7.html)
HR (1) HRP970292B1 (cg-RX-API-DMAC7.html)
HU (1) HUP9700955A3 (cg-RX-API-DMAC7.html)
ID (1) ID16989A (cg-RX-API-DMAC7.html)
IL (1) IL120924A (cg-RX-API-DMAC7.html)
NO (1) NO308527B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ314915A (cg-RX-API-DMAC7.html)
PL (1) PL185754B1 (cg-RX-API-DMAC7.html)
PT (1) PT810206E (cg-RX-API-DMAC7.html)
RU (1) RU2190600C2 (cg-RX-API-DMAC7.html)
SI (1) SI0810206T1 (cg-RX-API-DMAC7.html)
SK (1) SK282020B6 (cg-RX-API-DMAC7.html)
TR (1) TR199700428A2 (cg-RX-API-DMAC7.html)
TW (1) TW416944B (cg-RX-API-DMAC7.html)
ZA (1) ZA974665B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621482A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6395897B1 (en) 1999-03-02 2002-05-28 Boehringer Ingelheim Pharmaceuticals, Inc. Nitrile compounds useful as reversible inhibitors of #9 cathepsin 5
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
PE20040167A1 (es) * 2002-03-28 2004-05-26 Novartis Ag Amidas del acido sulfamico
JP4594386B2 (ja) * 2004-06-02 2010-12-08 エフ．ホフマン−ラ ロシュ アーゲー ヒスタミン３受容体のリガンドとして有用なナフタレン誘導体
TW200614995A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
AU2013205388B2 (en) * 2005-06-24 2016-05-05 Biotron Limited Antiviral compounds and methods
JP5373392B2 (ja) * 2005-06-24 2013-12-18 バイオトロン リミテッド 抗ウイルス化合物および方法
WO2008032204A1 (en) * 2006-09-15 2008-03-20 Pfizer Japan Inc. Substituted pyridylmethyl bicyclocarboxyamide compounds
EP2394988A4 (en) * 2009-02-09 2012-09-05 Astellas Pharma Inc SUBSTITUTED ACYLGUANIDINE DERIVATIVE
US20110306621A1 (en) * 2009-02-09 2011-12-15 Isao Kinoyama Acylguanidine derivatives
TW201116281A (en) 2009-08-06 2011-05-16 Astellas Pharma Inc N atom containing ring acylguanidine derivatives
PL2671869T3 (pl) 2011-02-02 2016-09-30 Pochodna tetrahydroizochinoliny

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251545A (en) * 1979-09-19 1981-02-17 Gaf Corporation Fungicidal process using 1-(alkoxyaroyl)guanidines
IT1238227B (it) * 1989-12-01 1993-07-12 Modulo di smistamento per impianti di convogliamento a nastro e simili
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4415873A1 (de) * 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JPH08225513A (ja) * 1994-12-21 1996-09-03 Kanebo Ltd ナフトイルグアニジン誘導体
DE19621482A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
TR199700428A2 (xx) 1997-12-21
PL185754B1 (pl) 2003-07-31
HU9700955D0 (en) 1997-07-28
KR970074776A (ko) 1997-12-10
AU2364597A (en) 1997-12-04
SK67097A3 (en) 1997-12-10
ES2154002T3 (es) 2001-03-16
CZ163097A3 (cs) 1998-06-17
MX9703922A (es) 1997-11-29
ZA974665B (en) 1997-12-01
PT810206E (pt) 2001-06-29
GR3035126T3 (en) 2001-03-30
IL120924A (en) 2002-03-10
NO972433L (no) 1997-12-01
US6087304A (en) 2000-07-11
JPH1081664A (ja) 1998-03-31
ID16989A (id) 1997-11-27
RU2190600C2 (ru) 2002-10-10
HUP9700955A2 (hu) 1998-03-02
EP0810206A1 (de) 1997-12-03
AR008373A1 (es) 2000-01-19
CN1167759A (zh) 1997-12-17
SI0810206T1 (en) 2001-04-30
DE59702802D1 (de) 2001-02-01
HRP970292B1 (en) 2001-08-31
NO972433D0 (no) 1997-05-28
HRP970292A2 (en) 1998-04-30
NZ314915A (en) 1998-02-26
CA2206366C (en) 2008-02-19
TW416944B (en) 2001-01-01
HUP9700955A3 (en) 1998-04-28
AU710065B2 (en) 1999-09-16
PL318723A1 (en) 1997-12-08
CA2206366A1 (en) 1997-11-29
ATE198320T1 (de) 2001-01-15
DE19621483A1 (de) 1997-12-04
SK282020B6 (sk) 2001-10-08
IL120924A0 (en) 1997-09-30
NO308527B1 (no) 2000-09-25
EP0810206B1 (de) 2000-12-27
DK0810206T3 (da) 2001-02-26
JP4039588B2 (ja) 2008-01-30

Similar Documents

Publication Publication Date Title
BR9605417A (pt) Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
BR9911914B1 (pt) n-arilamidas do ácido sulfonilaminocarboxìlico substituìdas por enxofre, processo para sua preparação, bem como preparações farmacêuticas que compreendem as mesmas.
PT807629E (pt) Cromanos substituidos por sulfonamidas processo para a sua preparacao a sua utilizacao como medicamentos ou agentes de diagnostico bem como medicamentos que os contem
PT1194403E (pt) Benzenocarbonamidas substituidas com indanilo, processo para a sua preparacao, sua utilizacao como medicamento bem como preparacoes farmaceuticas que as contem
BR9807502B1 (pt) compostos orgÂnicos, processo para sua preparaÇço, bem como composiÇço e aplicaÇço dos mesmos.
BR9707839A (pt) Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação
DE69700384D1 (de) Telemetriesystem, insbesondere für medizinische Zwecke
DE69803657D1 (de) Wiederverwendbares datenbanksystem
BR9801606B1 (pt) composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
PT964937E (pt) Po de tantalo processo para a sua preparacao assim como anodos sinterizados obtidos a partir desse po
ID20500A (id) Metoda untuk memperoleh asam akrilat
BR9703338A (pt) 2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm
PT100917A (pt) Heteroarilaminas que actuam como novos inibidores de acetilcolinesterase e processo para a sua preparacao
PT1098874E (pt) Benzociclo-heptenos processo para a sua sintese preparacoes farmaceuticas contendo estes compostos assim como sua utilizacao para a fabricacao de medicamentos
BR9607301A (pt) Processo para a preparação de nootkatone ou nootkatol
DE69737870D1 (de) Medikamente für die diagnostik von autoimmunerkrankungen
BR9603911A (pt) Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
BR1100524A (pt) Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas
BR9101638A (pt) Resina formadora de pegajosidade,processo para sua preparacao bem como usada mesma e composicao adesiva
BR9703342A (pt) 1-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm
BR9602337A (pt) Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento
BR9714066B1 (pt) processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço.
PT1015433E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos
BR9503565A (pt) Processo para a preparação de uma quinacridona substituída ou n o substituída
FI943853L (fi) Diasyylisubstituoidut guanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1834 DE 01/03/2006.